Abstract
The deleterious effects of corticosteroids (CS) on bone are well known, but probably differ depending on duration and dosage of CS therapy. Presently huge amounts of CS are given over a short period of time in different rheumatic conditions. Not much is known about the effect of this kind of CS treatment on bone metabolism. Twenty patients with persistently active rheumatoid arthritis were treated with 1 g methylprednisolone (MP) three times on alternate days over a five day period. Twenty four hours after the first MP pulse serum calcium was increased and the values of parathyroid hormone and 1,25-dihydroxyvitamin D tended to increase. After the second MP pulse, however, these values had returned to the starting values. The urinary calcium excretion increased during MP pulse therapy and returned to the initial value immediately after the pulse therapy. The hydroxyproline excretion tended to decrease during therapy and stayed decreased immediately afterwards, indicating a decrease in bone resorption. It is concluded that bone metabolism is not seriously affected during MP pulse therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Au W. Y. Cortisol stimulation of parathyroid hormone secretion by rat parathyroid glands in organ culture. Science. 1976 Sep 10;193(4257):1015–1017. doi: 10.1126/science.948759. [DOI] [PubMed] [Google Scholar]
- Bijlsma J. W., Duursma S. A., Bosch R., Huber O. Lack of influence of the anabolic steroid nandrolondecanoate on bone metabolism. Acta Endocrinol (Copenh) 1982 Sep;101(1):140–143. doi: 10.1530/acta.0.1010140. [DOI] [PubMed] [Google Scholar]
- Braun J. J., Juttmann J. R., Visser T. J., Birkenhäger J. C. Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism. Clin Endocrinol (Oxf) 1982 Jul 1;17(1):21–28. doi: 10.1111/j.1365-2265.1982.tb02630.x. [DOI] [PubMed] [Google Scholar]
- Bélanger L. F. Osteocytic osteolysis. Calcif Tissue Res. 1969 Aug 11;4(1):1–12. doi: 10.1007/BF02279101. [DOI] [PubMed] [Google Scholar]
- Fucik R. F., Kukreja S. C., Hargis G. K., Bowser E. N., Henderson W. J., Williams G. A. Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab. 1975 Jan;40(1):152–155. doi: 10.1210/jcem-40-1-152. [DOI] [PubMed] [Google Scholar]
- Mbuyi J. M., Dequeker J., Teblick M., Merlevede M. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis. J Rheumatol. 1982 Jul-Aug;9(4):579–583. [PubMed] [Google Scholar]
- Sambrook P. N., Ansell B. M., Foster S., Gumpel J. M., Hesp R., Reeve J., Zanelli J. M. Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes. Ann Rheum Dis. 1985 Sep;44(9):575–579. doi: 10.1136/ard.44.9.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Suzuki Y., Ichikawa Y., Saito E., Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism. 1983 Feb;32(2):151–156. doi: 10.1016/0026-0495(83)90221-4. [DOI] [PubMed] [Google Scholar]
- Williams I. A., Baylis E. M., Shipley M. E. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet. 1982 Jul 31;2(8292):237–240. doi: 10.1016/s0140-6736(82)90323-3. [DOI] [PubMed] [Google Scholar]
- Zerwekh J. E., Pak C. Y., Kaplan R. A., McGuire J. L., Upchurch K., Breslau N., Johnson R., Jr Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J Clin Endocrinol Metab. 1980 Aug;51(2):381–386. doi: 10.1210/jcem-51-2-381. [DOI] [PubMed] [Google Scholar]